Lasa Supergenerics Limited has reported Standalone financial results for the period ended June 30, 2022.
Financial Results (Q1 FY2023) - QoQ Comparison
The company has reported total income of Rs. 28.8874 crores during the period ended June 30, 2022 as compared to Rs. 51.2216 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs. -12.0839 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 12.2843 crores for the period ended March 31, 2022.
The company has reported EPS of Rs. -2.97 for the period ended June 30, 2022 as compared to Rs. 3.02 for the period ended March 31, 2022.
Total Income | ₹ 28.8874 crs | ₹51.2216 crs | -43.60% |
Net Profit | ₹-12.0839 crs | ₹12.2843 crs | -198.37% |
EPS | ₹-2.97 | ₹3.02 | -198.34% |
Financial Results (Q1 FY2023) - YoY Comparison The company has reported total income of Rs. 28.8874 crores during the period ended June 30, 2022 as compared to Rs.36.0805 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs.-12.0839 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.0.8060 crores for the period ended June 30, 2021.
The company has reported EPS of Rs.-2.97 for the period ended June 30, 2022 as compared to Rs.0.20 for the period ended June 30, 2021.
Total Income | ₹ 28.8874 crs | ₹36.0805 crs | -19.94% |
Net Profit | ₹-12.0839 crs | ₹0.8060 crs | -1,599.24% |
EPS | ₹-2.97 | ₹0.20 | -1,585.00% |
Shares of Lasa Supergenerics Limited was last trading in BSE at Rs. 38.40 as compared to the previous close of Rs. 37.95. The total number of shares traded during the day was 23912 in over 159 trades.
The stock hit an intraday high of Rs. 39.30 and intraday low of 36.55. The net turnover during the day was Rs. 918247.00.
Source : Equity Bulls
Keywords
LasaSupergenerics
Q1FY23
ResultUpdate